Abstract

Total and intra-mitochondrial gonadal cholesterol concentrations are decreased in fish exposed to the phytoestrogen beta-sitosterol (beta-sit). The present study examined the potential for beta-sit to disrupt de novo cholesterol synthesis in the gonads of goldfish exposed to 200 microgram/g beta-sit and 10 microgram/g 17beta-estradiol (E2; estrogenic control) by intra-peritoneal Silastic® implants for 21 days. The de novo cholesterol synthetic capacity was estimated by incubating gonadal tissue with 14C-acetate for a period of 18 hours, followed by chloroform/methanol lipid extraction and thin layer chromatography (TLC) lipid separation. Lipid classes were confirmed using infrared spectroscopy. Plasma testosterone (T) and total cholesterol concentration were measured and gonadosomatic index (GSI) was calculated. Plasma T was significantly reduced in male beta-sit-treated fish compared to control and E2-treated fish (p < 0.001). 14C-Acetate incorporation into cholesterol and cholesterol esters was not significantly different among treatment groups for male and female fish, however, 14C-enrichment was higher than expected in both triglycerides (TG) and free fatty acids (FFA). FFA incorporation was significantly higher in male control fish than either beta-sit or E2 treatments (p = 0.005). Plasma cholesterol concentration was significantly increased in the male beta-sit treatment group compared to controls (p = 0.027). These results indicate gonadal de novo cholesterol biosynthetic capacity is not disrupted by beta-sit or E2 treatment in early recrudescing male or female goldfish, while plasma cholesterol and steroid concentrations are sensitive to beta-sit exposure.

Highlights

  • Cholesterol is the precursor to all steroid hormones, such as estrogens, androgens, and corticosteroids [1]

  • Plasma T was significantly reduced in male beta-sit-treated fish compared to control and E2-treated fish (p < 0.001). 14C-Acetate incorporation into cholesterol and cholesterol esters was not significantly different among treatment groups for male and female fish, 14C-enrichment was higher than expected in both triglycerides (TG) and free fatty acids (FFA)

  • These results indicate gonadal de novo cholesterol biosynthetic capacity is not disrupted by betasit or E2 treatment in early recrudescing male or female goldfish, while plasma cholesterol and steroid concentrations are sensitive to beta-sit exposure

Read more

Summary

Introduction

Cholesterol is the precursor to all steroid hormones, such as estrogens, androgens, and corticosteroids [1]. As in other vertebrate species, cholesterol is obtained by dietary intake, release from intracellular stores or by de novo synthesis [2]. Reproductive Biology and Endocrinology 2006, 4:60 http://www.rbej.com/content/4/1/60 as the adrenal and ovary), some tissues (such as the testis) differentially utilize de novo synthesized cholesterol as a substrate for steroid biosynthesis [2,6]. The definitive mechanisms of cholesterol metabolism in fish are believed to be highly similar to mammals, comprehensive information on lipid dynamics in teleost species is limited. A number of reviews on animal [6,8,9] and fish [10] lipoprotein dynamics indicate structure is similar, TG content is elevated at the expense of cholesterol esters in teleost lipoproteins. The traditional detrimental affects associated with high plasma cholesterol such as coronary lesions and plaque formation are notably absent in fish species, presenting an interesting and stark contrast to the human condition

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call